publication venue for
- Unstable mutations in the FMR1 gene and the phenotypes.. 769:78-114. 2012
- Endoplasmic reticulum stress and BCL-2 family members. 687:65-77. 2010
- Enzyme mechanism and function of a novel plant PDI involved in the oxidative folding of cystine knot defense peptides.. 611:31-32. 2009
- Molecular imaging and orientational changes of antimicrobial peptides in membranes.. 611:313-315. 2009
- Cleavage of the Human C5a Receptor by Proteinases Derived from Porphyromonas gingivalis: Cleavage of Leukocyte C5a Receptor. 389:155-164. 1996
- Mechanisms of excitation-contraction coupling relevant to skeletal muscle fatigue. 384:45-56. 1995
- B-cell activation mediated by interactions with membranes from helper T cells. 323:139-148. 1992
- The effects of fasting and refeeding on in vitro lipogenesis and glycogen synthesis from U-14C-glucose in the rat aorta.. 82:300-302. 1977
- Biomaterials and regenerative medicine in urology 2018
- Genome-wide association studies and risk scores for coronary artery disease: Sex biases 2018
- Design principles of peptide based self-assembled nanomaterials 2017
- The IGF1-PI3K-Akt signaling pathway in mediating exercise-induced cardiac hypertrophy and protection 2017
- The role of cardiac tissue macrophages in homeostasis and disease 2017
- Transcriptional/Translational Regulation of Mammalian Spermatogenic Stem Cells 2013
- Polyglutamine aggregation in Huntington and related diseases 2012
- The lysine-specific gingipain of Porphyromonas gingivalis : importance to pathogenicity and potential strategies for inhibition. 2011
- Digital PCR of genomic rearrangements for monitoring circulating tumour DNA 2016
- Workshop summary: Novel aspects of the functions of the TRAFs and cIAPs 2011
- DcR2 PROTECTS CANCER CELLS FROM TRAIL-INDUCED APOPTOSIS BY ACTIVATING Akt 2011
- New Perspectives in TNF-R1-Induced NF-kappa B Signaling 2011
- Colonic cell proliferation, differentiation, and apoptosis 2000
- Recombinant expression and epitope mapping of grass pollen allergens 1996
- (S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): A potent antiherpesvirus agent 1990